SCHEMBL18722495

SCHEMBL18722495

CS(=O)(=O)Nc1cccc(CC(=O)NS)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 14/20 0.53
ALDH1A1 P00352 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CYP3A4 P08684 10/20 0.50
PRKACA P17612 2/20 0.50
ROCK2 O75116 2/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
POLB P06746 1/20 0.49
NR3C1 P04150 1/20 0.48
CIT O14578 1/20 0.45
MAP3K7 O43318 1/20 0.45
JAK2 O60674 1/20 0.45
RPS6KA5 O75582 1/20 0.45
RPS6KA4 O75676 1/20 0.45
PRKCG P05129 1/20 0.45
PRKCB P05771 1/20 0.45
CCNA2 P20248 1/20 0.45
RPS6KB1 P23443 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15834340 0.87 ROCK1 (0.54) ROCK1ALDH1A1SMN1; SMN2CYP3A4PRKACA
SCHEMBL2767758 0.83 ALDH1A1 (0.55) ROCK1ALDH1A1SMN1; SMN2CYP3A4PRKACA
SCHEMBL15831227 0.83 ROCK1 (0.54) ROCK1ALDH1A1SMN1; SMN2CYP3A4PRKACA
SCHEMBL13513281 0.82 ALDH1A1 (0.54) ROCK1ALDH1A1SMN1; SMN2CYP3A4PRKACA
Hydrochloric Acid SCHEMBL27533178 0.81 ALDH1A1 (0.53) ROCK1ALDH1A1SMN1; SMN2CYP3A4PRKACA
SCHEMBL2767849 0.81 POLB (0.57) ROCK1ALDH1A1SMN1; SMN2CYP3A4PRKACA
SCHEMBL18722496 0.80 ROCK1 (0.51) ROCK1ALDH1A1SMN1; SMN2CYP3A4PRKACA
SCHEMBL398666 0.78 ALDH1A1 (0.50) ROCK1ALDH1A1SMN1; SMN2CYP3A4PRKACA
SCHEMBL3560306 0.78 IKBKB (0.58) ALDH1A1SMN1; SMN2POLBNR3C1
SCHEMBL12440452 0.77 POLB (0.50) ROCK1ALDH1A1SMN1; SMN2CYP3A4PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9616064-B2 Rho kinase inhibitors and methods of use H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2017-04-11 US disclosed